Global research trends in tuberculosis drug-resistance mechanisms: a bibliometric and cross-database analysis
Background Drug-resistant tuberculosis (DR-TB) remains a major challenge to global tuberculosis control. In 2024, approximately 390,000 individuals developed multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB) worldwide, while treatment coverage remained limited to 42%, highlighting persistent gaps in DR-TB man...